SciELO - Scientific Electronic Library Online

 
vol.63 número4Conhecimentos e atitudes em relação à demência de estudantes de medicina brasileiros no final da graduaçãoAvaliação citopatológica no seguimento de pacientes submetidas à radioterapia por câncer de colo uterino índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Revista da Associação Médica Brasileira

versão impressa ISSN 0104-4230versão On-line ISSN 1806-9282

Resumo

BARROS-OLIVEIRA, Maria da Conceição et al. Use of anastrozole in the chemoprevention and treatment of breast cancer: A literature review. Rev. Assoc. Med. Bras. [online]. 2017, vol.63, n.4, pp.371-378. ISSN 1806-9282.  https://doi.org/10.1590/1806-9282.63.04.371.

Aromatase inhibitors have emerged as an alternative endocrine therapy for the treatment of hormone sensitive breast cancer in postmenopausal women. The use of third-generation inhibitors represented by exemestane, letrozol and anastrozole is currently indicated. Anastrozole is a nonsteroidal compound and a potent selective inhibitor of the aromatase enzyme. Although a few studies have shown that its pharmacodynamic and pharmacokinetic properties may be affected by interindividual variability, this drug has been recently used in all configurations of breast cancer treatment. In metastatic disease, it is currently considered the first-line treatment for postmenopausal women with estrogen receptor-positive breast tumors. Anastrozole has shown promising results in the adjuvant treatment of early-stage breast cancer in postmenopausal women. It has also achieved interesting results in the chemoprevention of the disease. Therefore, due to the importance of anastrozole both for endocrine treatment and chemoprevention of hormone-sensitive breast cancer in postmenopausal women, we proposed the current literature review in the SciELO and PubMed database of articles published in the last 10 years.

Palavras-chave : aromatase inhibitors; chemoprevention; breast neoplasms; pharmacokinetics.

        · resumo em Português     · texto em Inglês     · Inglês ( pdf )